astrazeneca-oxford-trial-covid-vaccine-moves-to-crucial-phase-with-$1-billion-in-us.-backing
The investment announced this week comes just as Oxford’s vaccine team enters a crucial phase in its human trials: expanding testing with the enrollment of more than 10,000 people, including children age 5 to 12, and people over 70.

###

By Arlene Huff

Arlene Huff is the founding member of Golden State Online. Before that She was a general assignment reporter. A native Californian, she graduated from the University of California with a degree in medical anthropology and global health. She currently lives in Los Angeles.

Leave a Reply

Your email address will not be published. Required fields are marked *